Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5698048 | Clinical Oncology | 2017 | 9 Pages |
Abstract
Our study showed acceptable levels of late grade 2 genitourinary toxicity and low rates of late grade 3 genitourinary toxicity in a cohort of patients with prostate cancer treated with image-guided IMRT to doses between 78 and 84 Gy. Variables associated with increased late ⥠2 genitourinary toxicity include previous TURP, alpha blocker use, hormone use and pre-existing urinary dysfunction.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
K. Byrne, G. Hruby, A. Kneebone, D. Whalley, L. Guo, P. McCloud, T. Eade,